blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3826620

EP3826620 - INHALATION COMPOSITIONS COMPRISING DOPAMINE AGONISTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.01.2024
Database last updated on 18.10.2024
FormerRequest for examination was made
Status updated on  30.04.2021
FormerThe international publication has been made
Status updated on  18.01.2020
Most recent event   Tooltip12.01.2024Application deemed to be withdrawnpublished on 14.02.2024  [2024/07]
Applicant(s)For all designated states
Arven Ilac Sanayi Ve Ticaret Anonim Sirketi
Istinye Mah. Balabandere Cad. No:14
Istinye
34460 Sariyer/Istanbul / TR
[2021/22]
Inventor(s)01 / TURKYILMAZ, Ali
Istinye Mah. Balabandere Caddesi No:14
34460 Istanbul / TR
02 / YENICE, Irem
Istinye Mah. Balabandere Caddesi No:14
34460 Istanbul / TR
03 / CELIK, Devrim
Istinye Mah. Balabandere Caddesi No:14
34460 Istanbul / TR
04 / CAYIR, Arzu
Istinye Mahallesi Balabandere Caddesi No:14
Istinye
34460 Sar yer/Istanbul / TR
 [2021/22]
Application number, filing date19833638.010.07.2019
[2021/22]
WO2019TR50555
Priority number, dateTR2018000993012.07.2018         Original published format: TR 201809930
[2021/22]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2020013793
Date:16.01.2020
Language:EN
[2020/03]
Type: A2 Application without search report 
No.:EP3826620
Date:02.06.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 16.01.2020 takes the place of the publication of the European patent application.
[2021/22]
Search report(s)International search report - published on:TR20.02.2020
(Supplementary) European search report - dispatched on:EP03.02.2023
ClassificationIPC:A61K9/72, A61P25/16, A61K31/473, A61M15/00
[2023/10]
CPC:
A61K9/0075 (EP); A61K31/473 (EP); A61P25/16 (EP);
A61M15/00 (EP); A61M2202/064 (EP)
Former IPC [2021/22]A61K9/72, A61K31/7016, A61P25/16
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/22]
TitleGerman:DOPAMINAGONISTEN ENTHALTENDE INHALATIONSZUSAMMENSETZUNGEN[2021/22]
English:INHALATION COMPOSITIONS COMPRISING DOPAMINE AGONISTS[2021/22]
French:COMPOSITIONS D'INHALATION COMPRENANT DES AGONISTES DE LA DOPAMINE[2021/22]
Entry into regional phase03.02.2021National basic fee paid 
03.02.2021Search fee paid 
03.02.2021Designation fee(s) paid 
03.02.2021Examination fee paid 
Examination procedure05.02.2021Examination requested  [2021/22]
30.05.2022Amendment by applicant (claims and/or description)
05.09.2023Application deemed to be withdrawn, date of legal effect  [2024/07]
27.09.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2024/07]
Fees paidRenewal fee
03.02.2021Renewal fee patent year 03
10.11.2022Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.07.202103   M06   Fee paid on   05.01.2022
31.07.202204   M06   Fee paid on   10.11.2022
31.07.202305   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0230390  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [X] 1,2,6-8,12 * page 1, line 3 - line 4 * * page 1, line 36 - page 5, line 28 * * page 7, line 34 - page 8, line 10 * * page 8, line 38 - line 39 * * claims 7,8 *;
 [XI]US2010018523  (STANIFORTH JOHN NICOLAS [GB], et al) [X] 1-10,12,13 * paragraph [0009] - paragraph [0036] * * paragraph [0077] - paragraph [0089] * * example - * * figure - * [I] 11;
 [XI]US2012321717  (STANIFORTH JOHN NICHOLAS [GB], et al) [X] 1-10,12,13 * example 2 * * claim - * [I] 11,14;
 [A]  - CHOUGULE MAHAVIR B ET AL, "Development of dry powder inhalers", RECENT PATENTS ON DRUG DELIVERY & FORMULATION, BENTHAM SCIENCE PUBLISHERS LTD, NL, (20070101), vol. 1, no. 1, ISSN 1872-2113, pages 11 - 21, XP002581085 [A] 1-14 * page 13, column r, paragraph 1 - paragraph 3 * * page 18, column r, paragraph 4 - paragraph 5 *
International search[XY]WO2009056851  (VECTURA LTD [GB], et al) [X] 1-7, 18 * Abstract, page 10 lines 6-8, page 17 lines 12- 30, page 19 lines 14-27, page 20 lines 22-27, page 21 lines 18-22, page 23 lines 18-26, page 24 lines 16-26, example 4. * [Y] 8-17;
 [Y]WO2013109210  (BILGIC MAHMUT [TR]) [Y] 8-17* Abstract, page 2 lines 17-28, page 3 lines 20-23, example 2, page 6 lines 14-22, claims. *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.